GBI Research provides intelligence from high-growth therapy areas and novel drug treatments to pioneering companies and their strategies
Our research services provide essential intelligence for executives, investors and researchers all working within the life sciences sector. Both individuals and companies can benefit from the vast amount of research areas which GBI Research covers.
We offer multiple research areas within our solution, with quality reports offering significant benefits to executives, investors and researchers. They enable companies and individuals to react quickly to new regulations and policies, helping them to align their product portfolio with the current market demand and supporting the development of strong market-entry strategies.
Our Research Service Modules:
Analysis of clinical trials, late stage pipeline activity and identification of trends in late stage and marketed products, as well as providing epidemiology, market sizing and forecast data
Focused on innovative drug discovery and development to assess the validity and strength of specific molecular targets and mechanisms of action for first-in-class products. Insights into longer term clinical and ultimately commercial opportunities
CBR Pharma Insights
Strategic assessment of key R&D, corporate, legislative and commercial issues and events shaping the pharma industry in both established and emerging markets